Gemcitabine in combination with capecitabine compared with gemcitabine combined with erlotinib in locally advanced or metastatic pancreatic cancer

被引：0

作者：

Khatri, P. ^{[1
]}

Kumari, P. ^{[2
]}

Beniwal, S. ^{[3
]}

Samdariya, S. ^{[4
]}

机构：

[1] Acharya Tulsi Canc Hosp & Res Ctr & Allied Hosp, Bikaner, India

[2] Acharya Tulsi Reg Canc Treatment & Res Ctr, Bikaner, India

[3] ATRCTRI, Bikaner, India

[4] AIIMS Jodhpur, Jodhpur, Rajasthan, India

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

RM-028

引用

页码：92 / 92

页数：1

共 50 条

[21] Phase I trial of capecitabine and gemcitabine with radiotherapy in locally advanced pancreatic cancer
Leong, T.
Michael, M.
Price, T.
Ganju, V
Strickland, A.
Jefford, M.
Muller, A.
Ngan, S.
Milner, A.
Zalcberg, J.
ANNALS OF ONCOLOGY, 2006, 17 : 34 - 34
[22] Intravenous vitamin C in combination with gemcitabine and erlotinib in subjects with metastatic pancreatic cancer
Monti, D.
Newberg, A.
Littman, S. J.
Mathews, M.
Lewis, N.
Mitchell, E. P.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[23] A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer
Sanghvi, Samrat M.
Coffman, Alex R.
Hsueh, Chung-Tsen
Kang, Joseph
Park, Annie
Solomon, Naveenraj L.
Garberoglio, Carlos A.
Reeves, Mark E.
Slater, Jerry D.
Yang, Gary Y.
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, : 1989 - 1996
[24] Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
Roberto Petrioli
Giandomenico Roviello
Anna Ida Fiaschi
Letizia Laera
Daniele Marrelli
Franco Roviello
Edoardo Francini
Cancer Chemotherapy and Pharmacology, 2015, 75 : 683 - 690
[25] Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
Brodowicz, T
Wolfram, RM
Köstler, WJ
Tomek, S
Vaclavik, I
Steger, GG
Teleky, B
Függer, R
Jakesz, R
Zielinski, CC
ANTI-CANCER DRUGS, 2000, 11 (08) : 623 - 628
[26] Combination Chemoherapy with S-1 and Gemcitabine for Locally Advanced and/or Metastatic Unresectable Pancreatic Cancer
Takayama, Yukiko
Shimizu, Kyoko
Tahara, Junko
Oyama, Hiroyasu
Hayashi, Kazuhiko
Shiratori, Keiko
GASTROENTEROLOGY, 2009, 136 (05) : A314 - A314
[27] Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer
Yaman Suleiman
Amit Mahipal
David Shibata
Erin M. Siegel
Helen Jump
William J. Fulp
Gregory M. Springett
Richard Kim
Cancer Chemotherapy and Pharmacology, 2015, 76 : 481 - 487
[28] Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
Petrioli, Roberto
Roviello, Giandomenico
Fiaschi, Anna Ida
Laera, Letizia
Marrelli, Daniele
Roviello, Franco
Francini, Edoardo
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 683 - 690
[29] Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer
Ishikawa, Takeshi
Kokura, Satoshi
Sakamoto, Naoyuki
Ando, Takashi
Imamoto, Eiko
Hattori, Takeshi
Oyamada, Hirokazu
Yoshinami, Naomi
Sakamoto, Masafumi
Kitagawa, Kazutomo
Okumura, Yoko
Yoshida, Naohisa
Kamada, Kazuhiro
Katada, Kazuhiro
Uchiyama, Kazuhiko
Handa, Osamu
Takagi, Tomohisa
Yasuda, Hiroaki
Sakagami, Junichi
Konishi, Hideyuki
Yagi, Nobuaki
Naito, Yuji
Yoshikawa, Toshikazu
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2012, 28 (07) : 597 - 604
[30] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
Hwang, In Gyu
Jang, Joung-Soon
Oh, Sung Yong
Lee, Suee
Kwon, Hyuk Chan
Lee, Gyeong Won
Go, Seil
Kang, Myoung Hee
Cha, Young Joo
Kang, Jung Hun
INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2371 - 2376

← 1 2 3 4 5 →